{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:10Z","timestamp":1786990390689,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijcard.2018.01.099","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T04:55:58Z","timestamp":1528260958000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II"],"prefix":"10.1016","volume":"265","author":[{"given":"Bryan P.","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Tien","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baishali","family":"Ambegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Horack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Lautsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-2494","authenticated-orcid":false,"given":"Ami","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm K.","family":"Gitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.01.099_bb0005","unstructured":"World Health Organization. Health statistics and information systems: Estimates for 2000\u20132015 [Available from: http:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates\/en\/index1.html]. Accessed: June 2017."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ijcard.2015.04.073","article-title":"Du X, Eccleston D, et al. Acute coronary syndrome in the Asia-Pacific region","volume":"202","author":"Chan","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2018.01.099_bb0015","first-page":"1646","article-title":"Cardiovascular disease epidemiology in Asia: an overview","volume":"77","author":"Ohira","year":"2013","journal-title":"Circulationjournal : official journal of the Japanese Circulation Society"},{"issue":"3","key":"10.1016\/j.ijcard.2018.01.099_bb0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacc.2008.09.041","article-title":"Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART study","volume":"53","author":"Karthikeyan","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9438","key":"10.1016\/j.ijcard.2018.01.099_bb0025","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.ijcard.2018.01.099_bb0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ije\/dyg106","article-title":"Cholesterol, coronary heart disease, and stroke in the Asia Pacific region","volume":"32","author":"Zhang","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"9493","key":"10.1016\/j.ijcard.2018.01.099_bb0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0040","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2018.01.099_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5551\/jat.31179","article-title":"Suboptimal control of lipid levels: results from 29 countries participating in the centralized pan-regional surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS).","volume":"23","author":"Chiang","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"issue":"5","key":"10.1016\/j.ijcard.2018.01.099_bb0050","first-page":"395","article-title":"The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre","volume":"18","author":"Chan","year":"2012","journal-title":"Hong Kong medical journal\u202f=\u202fXianggang yi xue za zhi."},{"issue":"4","key":"10.1016\/j.ijcard.2018.01.099_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jfma.2016.11.013","article-title":"Taiwan lipid guidelines for high risk patients","volume":"116","author":"Li","year":"2017","journal-title":"Journal of the Formosan Medical Association\u202f=\u202fTaiwan yi zhi"},{"key":"10.1016\/j.ijcard.2018.01.099_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12872-015-0117-y","article-title":"How low should we target the LDL goal to improve survival for acute coronary syndrome patients in Hong Kong?","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"issue":"11","key":"10.1016\/j.ijcard.2018.01.099_bb0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jfma.2013.08.001","article-title":"Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry","volume":"113","author":"Chiang","year":"2014","journal-title":"Journal of the Formosan Medical Association\u202f=\u202fTaiwan yi zhi"},{"issue":"14","key":"10.1016\/j.ijcard.2018.01.099_bb0070","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al.","year":"2011","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2018.01.099_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"issue":"5A","key":"10.1016\/j.ijcard.2018.01.099_bb0080","doi-asserted-by":"crossref","first-page":"24F","DOI":"10.1016\/j.amjcard.2005.06.009","article-title":"Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol","volume":"96","author":"Liao","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.01.099_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/eci.12255","article-title":"Update on the efficacy of statin treatment in acute coronary syndromes","volume":"44","author":"Rosa","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.ijcard.2018.01.099_bb0090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/1741826710397100","article-title":"Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS pan-Asian survey","volume":"19","author":"Park","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0095","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.dib.2016.09.037","article-title":"Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world","volume":"9","author":"Gitt","year":"2016","journal-title":"Data in brief."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.09.004","article-title":"Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients","volume":"255","author":"Gitt","year":"2016","journal-title":"Atherosclerosis."},{"issue":"4","key":"10.1016\/j.ijcard.2018.01.099_bb0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment","volume":"78","author":"Lee","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2018.01.099_bb0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00228-014-1800-0","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States","volume":"71","author":"Birmingham","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2261-15-6","article-title":"The difference between Asian and western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1756-0500-5-251","article-title":"Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial","volume":"5","author":"Yu","year":"2012","journal-title":"BMC research notes."},{"issue":"25","key":"10.1016\/j.ijcard.2018.01.099_bb0125","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.01.099_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2017.02.006","article-title":"Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: a 6-year population-based cohort study","volume":"233","author":"Lin Wu","year":"2017","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317365889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317365889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:39:30Z","timestamp":1759091970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317365889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":26,"alternative-id":["S0167527317365889"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.099","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}